sphingotec and Mayo Clinic Collaborate to Take Novel Biomarkers from Research to Clinical Use in Educational Webinar

Share Article

In this webinar, which LabRoots will host January 23, attendees will learn of the importance and challenges of analytical validations of assays for novel biomarkers.

The translation of basic scientific research to clinical application in the hospital or clinic setting is vital for advancing the quality of patient care. This is particularly true in the clinical laboratory setting, where physicians, scientists, and laboratorians evaluate new biomarkers for potential clinical use.

The numerous steps taken to evaluate the analytical and clinical performance of a novel biomarker are critical to this process before a test can be offered and ordered by health care providers. These steps ensure the test results are accurate and reproducible when performed by laboratory technologists and confirm that results can be used to improve disease diagnostics or prognostics.

In this webinar, which is sponsored by sphingotec GmbH, participants will gain a better understanding of what factors are important to consider when deciding which novel biomarker to evaluate for clinical use. They will learn the importance and challenges of clinical validations of assays using novel biomarkers.

The speakers will describe the process a major academic medical center takes to critically evaluate novel biomarkers for various clinical applications and provide examples of such biomarkers that are either under evaluation or have been recently completed. The presenters sphingotec selected for this webinar include:

Allan Jaffe, M.D., chair of the Division of Clinical Core Laboratory Services in the Department of Laboratory Medicine and Pathology at Mayo Clinic

Jeff Meeusen, Ph.D., co-director of Cardiovascular Laboratory Medicine at Mayo Clinic

Leslie Donato, Ph.D., co-director of both Cardiovascular Laboratory Medicine and the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic

LabRoots will host the webinar January 23, 2018, at 12 p.m. PST, 2 p.m. CST, and 3 p.m. EST. To read more about this event, learn of the continuing education credits that will be offered, or to register for free, click here.

About sphingotec GmbH
sphingotec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. For more information, visit http://www.sphingotec.com.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or newsnetwork.mayoclinic.org.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website